Skip to main content

The Relationship Between Lymph Node Ratio and Survival Benefit With Adjuvant Chemotherapy in Node-positive Esophageal Adenocarcinoma.

Publication ,  Journal Article
Raman, V; Jawitz, OK; Farrow, NE; Voigt, SL; Rhodin, KE; Yang, C-FJ; Turner, MC; D'Amico, TA; Harpole, DH; Tong, BC
Published in: Ann Surg
March 1, 2022

BACKGROUND: We hypothesized that the ratio of positive lymph nodes to total assessed lymph nodes (LNR) is an indicator of cancer burden in esophageal adenocarcinoma and may identify patients who may most benefit from AC. OBJECTIVE: The aim of this study was to discern whether there is a threshold LNR above which AC is associated with a survival benefit in this population. METHODS: The 2004-2015 National Cancer Database was queried for patients who underwent upfront, complete resection of pT1-4N1-3M0 esophageal adenocarcinoma. The primary outcome, overall survival, was examined using multivariable Cox proportional hazards models employing an interaction term between LNR and AC. RESULTS: A total of 1733 patients were included: 811 (47%) did not receive AC whereas 922 (53%) did. The median LNR was 20% (interquartile range 9-40). In a multivariable Cox model, the interaction term between LNR and receipt of AC was significant (P = 0.01). A plot of the interaction demonstrated that AC was associated with improved survival beyond a LNR of about 10%-12%. In a sensitivity analysis, the receipt of AC was not associated with improved survival in patients with LNR <12% (hazard ratio 1.02; 95% confidence interval 0.72-1.44) but was associated with improved survival in those with LNR ≥12% (hazard ratio 0.65; 95% confidence interval 0.50-0.79). CONCLUSIONS: In this study of patients with upfront, complete resection of node-positive esophageal adenocarcinoma, AC was associated with improved survival for LNR ≥12%. LNR may be used as an adjunct in multidisciplinary decision-making about adjuvant therapies in this patient population.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Ann Surg

DOI

EISSN

1528-1140

Publication Date

March 1, 2022

Volume

275

Issue

3

Start / End Page

e562 / e567

Location

United States

Related Subject Headings

  • Survival Rate
  • Surgery
  • Retrospective Studies
  • Middle Aged
  • Male
  • Lymph Node Ratio
  • Humans
  • Female
  • Esophageal Neoplasms
  • Cohort Studies
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Raman, V., Jawitz, O. K., Farrow, N. E., Voigt, S. L., Rhodin, K. E., Yang, C.-F., … Tong, B. C. (2022). The Relationship Between Lymph Node Ratio and Survival Benefit With Adjuvant Chemotherapy in Node-positive Esophageal Adenocarcinoma. Ann Surg, 275(3), e562–e567. https://doi.org/10.1097/SLA.0000000000004150
Raman, Vignesh, Oliver K. Jawitz, Norma E. Farrow, Soraya L. Voigt, Kristen E. Rhodin, Chi-Fu J. Yang, Megan C. Turner, Thomas A. D’Amico, David H. Harpole, and Betty C. Tong. “The Relationship Between Lymph Node Ratio and Survival Benefit With Adjuvant Chemotherapy in Node-positive Esophageal Adenocarcinoma.Ann Surg 275, no. 3 (March 1, 2022): e562–67. https://doi.org/10.1097/SLA.0000000000004150.
Raman V, Jawitz OK, Farrow NE, Voigt SL, Rhodin KE, Yang C-FJ, et al. The Relationship Between Lymph Node Ratio and Survival Benefit With Adjuvant Chemotherapy in Node-positive Esophageal Adenocarcinoma. Ann Surg. 2022 Mar 1;275(3):e562–7.
Raman, Vignesh, et al. “The Relationship Between Lymph Node Ratio and Survival Benefit With Adjuvant Chemotherapy in Node-positive Esophageal Adenocarcinoma.Ann Surg, vol. 275, no. 3, Mar. 2022, pp. e562–67. Pubmed, doi:10.1097/SLA.0000000000004150.
Raman V, Jawitz OK, Farrow NE, Voigt SL, Rhodin KE, Yang C-FJ, Turner MC, D’Amico TA, Harpole DH, Tong BC. The Relationship Between Lymph Node Ratio and Survival Benefit With Adjuvant Chemotherapy in Node-positive Esophageal Adenocarcinoma. Ann Surg. 2022 Mar 1;275(3):e562–e567.

Published In

Ann Surg

DOI

EISSN

1528-1140

Publication Date

March 1, 2022

Volume

275

Issue

3

Start / End Page

e562 / e567

Location

United States

Related Subject Headings

  • Survival Rate
  • Surgery
  • Retrospective Studies
  • Middle Aged
  • Male
  • Lymph Node Ratio
  • Humans
  • Female
  • Esophageal Neoplasms
  • Cohort Studies